- Country: Belarus
- Summary: 25/04-4 Antitumor Drug Crizotinib
- BYT Ref No: 130577193
- Deadline: 05 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: BYN 51159600
- Notice Type: Tender
- Document Ref. No.: AU20251119355350
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- 25/04-4 Antitumor drug Crizotinib
- Documents:
Dogovor_k_auktzionnym__dokumentam_SOS_2025_rezidenty__proizvoditeli.doc
Dogovor_k_auktzionnym__dokumentam_SOS_2025_rezidenty_posredniki.doc
Kontrakt_k_auktzionnym__dokumentam_SOS_2025_nerezidenty.doc
Prilogenie__3_lyubaya_valyuta.xlsx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN25/04-4 Antitumor Drug Crizotinib - Belarus Tender
The RUE "BELPHARMATSIYA", a Government sector organization in Belarus, has announced a new tender for 25/04-4 Antitumor Drug Crizotinib. This tender is published on BelarusTenders under BYT Ref No: 130577193 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-05.
The estimated tender value is BYN 51159600, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
